it's commercialisation time

I've been very quiet lately, keeping powder dry -- but am back into TIS at 0.53 over the last week. So much has happened in the last 12 months and this company is on the verge of something special IMO yet the share price is still in the low 0.50's.

A quick recap on recent progress:
- successful capital raising
- ramp up of commercial quantities of VitroGrow
- EU trial results (confirming what we all know -- VitroGrow is awesome)
- FDA classification

We know the product works, we know there is a huge market, we know the market NEEDS VitroGrow.

If a commercial partner was waiting for anything -- it's all ready to roll now so there's no excuses remaining. A commercial partner will wait until the last minute to try and secure the best possible deal and reduce their risk -- that's business. Everything is in place for sales in Q2 2012, so a commercialisation deal now will make more sense than before.

As you expect with new technology (and especially biotechs) you get setbacks from time to time. You can criticise management for missing previous deadlines, however they have to release to market what they reasonably expect to happen.

I suspect management will have the last laugh.

PS: I'm also fairly optimistic about a sign on bonus. I'm thinking $50m +

Good luck all -- I wish I was attending the AGM, but I'll have to follow on HC instead.